Avieum Life Sciences Private Limited, a active private limited company, was established on 11 January 2017 in Pune, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100PN2017PTC167898. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.40 M and a paid-up capital of ₹0.32 M.
It upholds a compliant status. Employing 49 professional, Its leadership includes Ramesh Ratan Kale (Director), Vanita Ramesh Kale (Director), Sanjay Iresh Chandake (Director). Past directors included Sanjay Iresh Chandake, Vikram Khanderao Chede, Prerana Sambhaji Patil. It holds ₹2.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at International Biotech Park, Genesis Square, Gr Flr Midc, Hinjewadi Phase Ii, Village Mann, Pune, Maharashtra, 411057.
U73100PN2017PTC167898
167898
11 January 2017
₹0.40 M
₹0.32 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Avieum Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Ratan Kale | Director | 11 Jan 2017 | Current |
| Vanita Ramesh Kale | Director | 11 Jan 2017 | Current |
| Sanjay Iresh Chandake | Director | 20 Jan 2018 | Current |
| Ravindra Devram Wakchaure | Director | 26 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 06 Jul 2021 | Past |
| Pramod Abcsdd | Director | 01 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avieum Life Sciences Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 544.72% increase. The company also saw a substantial fall in profitability, with a 34.58% decrease in profit. The company's net worth Soared by an impressive increase of 156.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Avieum Life Sciences had a promoter holding of 64.57% and a public holding of 35.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹27,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2017 | Bank Of India | ₹2.75 Cr | Open |
Explore comprehensive loan charge details -
Avieum Life Sciences has a workforce of 49 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Avieum Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avieum Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ravindra Devram Wakchaure was appointed as a Director was appointed as a Director on 26 Dec 2019 & has been associated with this company since 5 years 11 months . was recorded as a recent event.
Progress on Avieum Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
The activity Avieum Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Pune. was completed.
The activity Sanjay Iresh Chandake was appointed as a Director was appointed as a Director on 20 Jan 2018 & has been associated with this company since 7 years 10 months . was completed.
The activity A charge with Bank Of India amounted to Rs. 27.50 M with Charge ID 100142021 was registered on 29 Nov 2017. was completed.
Progress on Ramesh Ratan Kale was appointed as a Director was appointed as a Director on 11 Jan 2017 & has been associated with this company since 8 years 11 months . was documented.
The CIN of Avieum Life Sciences Private Limited is U73100PN2017PTC167898.
Avieum Life Sciences Private Limited is headquartered at International Biotech Park, Genesis Square, Gr Flr Midc, Hinjewadi Phase Ii, Village Mann, Pune, Maharashtra, 411057.
Avieum Life Sciences Private Limited was incorporated on 11 January 2017.
The current directors of Avieum Life Sciences Private Limited are
The primary industry of Avieum Life Sciences Private Limited is Professional, Scientific And Technical.
Avieum Life Sciences Private Limited is unlisted.
The authorized capital of Avieum Life Sciences Private Limited is ₹0.40 M, and the paid-up capital is ₹0.32 M.
The compliance status of Avieum Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX